Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01087957 · ClinicalTrials.gov registry record · NA
WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients
A NA study, sponsored by Innovative Neurotronics.
- Completed
- Registry status
- NA
- Development phase
- 495
- Enrollment target
NCT01087957: Completed NA study, sponsored by Innovative Neurotronics.
NCT01087957 is a NA study that has completed, run by Innovative Neurotronics. The registered enrollment target is 495 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01087957, a NA study, has completed, sponsored by Innovative Neurotronics.
- COMPLETED
- Registry status
- NA
- Development phase
- 495 participants
- Enrollment target
Study Summary
To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.
Interventions
- DEVICE WalkAide
- OTHER Ankle-Foot Orthosis (AFO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01087957
The ClinicalTrials.gov registry entry for NCT01087957 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 495 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Neurotronics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WalkAide is the first listed.
NCT01087957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01087957 about?
NCT01087957 is a clinical study titled "WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients". To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.
What is the current status of trial NCT01087957?
This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2010-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01087957?
The interventions under investigation include: WalkAide (DEVICE), Ankle-Foot Orthosis (AFO) (OTHER).
Who is sponsoring clinical trial NCT01087957?
This trial is sponsored by Innovative Neurotronics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.